NEXT Dallas — Irving, Texas

NEXT Dallas is a clinical research site located in Irving, Texas, United States 75039.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

NEXT Dallas has participated in 15 clinical trials with 14 currently active.

Therapeutic areas: Advanced Solid Tumors, Solid Tumors, Solid Tumor.

Sponsors: Vividion Therapeutics, Inc., Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD., ImmunoGenesis.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Dallas?

NEXT Dallas has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Dallas conducted?

NEXT Dallas has 15 clinical trials on record, with 14 currently active. Their work covers Advanced Solid Tumors, Solid Tumors, Solid Tumor.

Is NEXT Dallas accredited by Crixeo Health?

NEXT Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.